CS
AGN

Cannell & Spears’s Allergan plc AGN Stock Holding History

Cannell & Spears’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-77,712
Closed -$14.9M – 258
2019
Q4 		$14.9M Sell
77,712
-32,812
-30% -$5.92M 1.59% 23
2019
Q3 		$18.6M Sell
110,524
-7,139
-6% -$1.16M 2.16% 21
2019
Q2 		$19.7M Sell
117,663
-2,494
-2% -$345K 2.31% 21
2019
Q1 		$17.6M Buy
120,157
+675
+0.6% +$97.9K 2.24% 22
2018
Q4 		$16M Sell
119,482
-11,305
-9% -$1.85M 2.34% 20
2018
Q3 		$24.9M Buy
130,787
+4,787
+4% +$879K 2.98% 13
2018
Q2 		$21M Buy
126,000
+25,243
+25% +$4.05M 2.73% 19
2018
Q1 		$17M Buy
100,757
+6,901
+7% +$1.16M 2.21% 21
2017
Q4 		$15.4M Sell
93,856
-8,518
-8% -$1.53M 1.87% 22
2017
Q3 		$21M Buy
102,374
+4,625
+5% +$1.08M 2.51% 20
2017
Q2 		$23.8M Sell
97,749
-4,107
-4% -$965K 2.95% 17
2017
Q1 		$24.3M Buy
101,856
+202
+0.2% +$47K 3.08% 16
2016
Q4 		$21.3M Sell
101,654
-37,121
-27% -$7.69M 2.74% 18
2016
Q3 		$32M Sell
138,775
-11,074
-7% -$2.71M 4.02% 10
2016
Q2 		$34.6M Buy
149,849
+32,092
+27% +$7.4M 4.39% 8
2016
Q1 		$31.6M Sell
117,757
-681
-0.6% -$195K 3.85% 12
2015
Q4 		$37M Buy
118,438
+31,438
+36% +$9.36M 4.23% 8
2015
Q3 		$23.6M Buy
87,000
+1,574
+2% +$483K 2.7% 21
2015
Q2 		$25.9M Buy
+85,426
New +$25.5M 2.87% 17

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Cannell & Spears's AGN Position: Q1 2020 in Review

Cannell & Spears sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 77,712 shares — an estimated $14.9M sold.

Cannell & Spears first reported a position in AGN in Q2 2015 and held it in 19 quarters. The position peaked at $37M in Q4 2015. 875 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Cannell & Spears reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Cannell & Spears sold 77,712 Allergan plc shares in Q1 2020, an estimated $14.9M.
  • Cannell & Spears first reported a position in Allergan plc in Q2 2015 and held it in 19 quarters.
  • Cannell & Spears's Allergan plc position peaked at $37M in Q4 2015.
  • 875 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Cannell & Spears's 13F filing for Q1 2020, filed 15 May 2020.